May 14 |
UNITY Biotechnology, Inc. Reports First Quarter 2024 Financial Results and Business Updates
|
Apr 25 |
UNITY Biotechnology Announces Upcoming Presentations at the ARVO 2024 Annual Meeting
|
Apr 23 |
UNITY Biotechnology Announces Extension of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 in DME
|
Apr 17 |
Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
|
Apr 15 |
Unity Biotechnology GAAP EPS of -$0.28 beats by $0.49
|
Apr 15 |
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
|